Pathway / Interaction Diagram
Mermaid diagram (expand to render)
Overview
ATG10 (Autophagy Related 10) encodes an E2-like conjugating enzyme that plays an essential role in the autophagy conjugation system. This enzyme catalyzes the covalent attachment of ATG12 to ATG5, a critical step in autophagosome formation that is fundamental to cellular protein quality control and organelle clearance[^1][^2]. ATG10 is widely expressed in tissues throughout the body, with particularly important functions in neurons where autophagy is crucial for synaptic maintenance, mitochondrial quality control, and clearance of misfolded proteins[^3].
The autophagy pathway, mediated by ATG10 and related proteins, has emerged as a critical protective mechanism in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Dysregulation of ATG10-mediated autophagy contributes to the accumulation of protein aggregates that characterize these conditions[^4][^5]. Genetic variants in ATG10 have been associated with altered disease risk, making it both a biomarker and potential therapeutic target.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Autophagy Related 10</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ATG10</td></tr>
<tr><td><strong>Full Name</strong></td><td>Autophagy Related 10</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5q21.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[94550](https://www.ncbi.nlm.nih.gov/gene/94550)</td></tr>
<tr><td><strong>OMIM</strong></td><td>610070</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000138107</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y4K0](https://www.uniprot.org/uniprot/Q9Y4K0)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>E2 conjugating enzyme, autophagy</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), ALS, Cancer</td></tr>
</table>
</div>
Gene Structure and Protein Architecture
Gene Organization
The human ATG10 gene is located on chromosome 5q21.3 and encodes a protein of 182 amino acids with a molecular weight of approximately 21 kDa. The gene consists of multiple exons and is conserved across eukaryotes, with orthologs in yeast (Atg10), mouse (Atg10), and other species[^1].
Protein Domains
The ATG10 protein possesses several key structural features:
E2 Enzyme Core Domain: The central portion of ATG10 contains the catalytic cysteine residue (Cys125 in humans) that forms a thioester intermediate with the C-terminal glycine of ATG12 during the conjugation reaction[^2].
ATG12 Binding Region: The N-terminal region mediates specific interaction with ATG12, the ubiquitin-like protein that ATG10 conjugates to ATG5.
ATG5 Interaction Surface: The C-terminal portion facilitates the transfer of ATG12 to ATG5, forming the ATG12-ATG5 conjugate.
Dimerization Domain: ATG10 can form homodimers, which may regulate its enzymatic activity and cellular localization[^6].The Autophagy Conjugation System
The ATG12-ATG5 Conjugation Cascade
ATG10 functions within the canonical autophagy conjugation system:
ATG12 Activation: The E1-like enzyme ATG7 activates ATG12 by forming a thioester bond at its C-terminal glycine[^7].
ATG12 Transfer to ATG10: Activated ATG12 is transferred to the active site cysteine of ATG10 (E2 enzyme), forming an ATG10-ATG12 thioester intermediate[^2].
ATG12-ATG5 Conjugation: ATG10 catalyzes the formation of an isopeptide bond between the C-terminal glycine of ATG12 and a specific lysine residue (Lys130) in ATG5[^8].
Complex Formation: The ATG12-ATG5 conjugate non-covalently associates with ATG16L1 to form the ATG12-ATG5-ATG16L1 complex, which functions as an E3-like enzyme for LC3 lipidation.Role in Autophagosome Biogenesis
The ATG12-ATG5-ATG16L1 complex is essential for autophagosome formation:
Isolation Membrane Recruitment: The complex localizes to the nascent isolation membrane (phagophore) and promotes its expansion.
LC3 Lipidation: The complex acts as an E3 enzyme for the lipidation of LC3 (MAP1LC3A), converting LC3-I to LC3-II[^9].
Autophagosome Closure: LC3-II mediates tethering and fusion events that lead to complete autophagosome formation.
Cargo Recognition: LC3-II on the inner autophagosomal membrane recognizes selective autophagy receptors.Biological Functions of ATG10
Cellular Homeostasis
ATG10-mediated autophagy is essential for cellular homeostasis:
Protein Quality Control: Autophagy clears misfolded proteins and protein aggregates that accumulate during cellular stress[^4].
Organelle Turnover: Mitophagy (mitochondrial autophagy) removes damaged mitochondria through ATG10-dependent mechanisms.
Lipid Metabolism: Autophagy regulates lipid droplet mobilization and cellular lipid homeostasis.
ER Clearance: Autophagy participates in endoplasmic reticulum quality control through reticulophagy.Neuronal Functions
In neurons, ATG10-mediated autophagy has specialized functions:
Synaptic Plasticity: Autophagy regulates synaptic vesicle turnover and dendritic spine morphology[^10].
Axonal Transport: Autophagosomes are transported along axons to deliver cargo to lysosomes.
Mitochondrial Quality Control: Neuronal mitochondria have high metabolic demands and require efficient quality control via mitophagy[^3].
Protein Aggregate Clearance: Neuronal autophagy must handle the high load of misfolded proteins associated with neurodegeneration.Stress Response
ATG10 expression and activity are regulated by cellular stress:
- Nutrient Deprivation: Starvation strongly induces autophagy through ATG10-dependent mechanisms[^1]
- Oxidative Stress: Reactive oxygen species activate autophagy as a protective response
- ER Stress: The unfolded protein response (UPR) intersects with autophagy pathways
- Hypoxia: Hypoxic conditions induce ATG10 expression and autophagy
ATG10 in Alzheimer's Disease
Evidence of ATG10 Dysregulation in AD
Multiple studies have documented ATG10 alterations in Alzheimer's disease:
Expression Studies: ATG10 expression is reduced in AD brain tissue, particularly in vulnerable regions like the hippocampus and entorhinal cortex[^11].
AD Models: In cellular and animal models of AD, ATG10 levels correlate with amyloid-beta (Aβ) burden and neuronal viability[^5].
Genetic Associations: Polymorphisms in the ATG10 promoter region have been associated with AD risk in some populations[^12].Mechanisms of ATG10 Dysfunction in AD
The relationship between ATG10 and AD pathology involves several mechanisms:
Autophagic Flux Impairment: Aβ accumulation impairs autophagic flux, reducing ATG10 effectiveness[^5].
Lysosomal Dysfunction: AD-related lysosomal abnormalities prevent proper autophagosome-lysosome fusion.
Protein Aggregation Load: Excessive Aβ and tau aggregates overwhelm the autophagy system.
Transcriptional Dysregulation: Transcription factors regulating ATG10 expression may be altered in AD.Therapeutic Targeting of ATG10 in AD
Targeting ATG10 and the autophagy pathway represents a therapeutic strategy:
| Strategy | Approach | Status | References |
|----------|----------|--------|------------|
| ATG10 expression | Viral vector-mediated overexpression | Preclinical | [^13] |
| Autophagy enhancers | Rapamycin, trehalose | Clinical trials | [^14] |
| Small molecule activators | ATG10-specific activators | Research | [^15] |
| Gene therapy | AAV-ATG10 delivery | Research | [^13] |
Trehalose and rapamycin are autophagy inducers that have shown promise in AD models, though their effects involve multiple autophagy pathways beyond ATG10[^14].
ATG10 in Parkinson's Disease
ATG10 and Alpha-Synuclein Clearance
ATG10-mediated autophagy is particularly relevant to Parkinson's disease:
α-Synuclein Turnover: Autophagy, including the ATG12-ATG5 system, degrades α-synuclein aggregates[^16].
PD Models: In cellular models of α-synucleinopathy, ATG10 overexpression enhances aggregate clearance[^17].
Genetic Links: ATG10 polymorphisms have been associated with PD risk in some studies, though results vary by population[^18].Mitophagy in PD
ATG10 participates in mitophagy, which is particularly relevant to PD:
Mitochondrial Dysfunction: PD is characterized by mitochondrial defects in dopaminergic neurons.
PINK1/Parkin Pathway: The canonical mitophagy pathway involves PINK1 and Parkin, with ATG10 providing supporting functions[^19].
Dopaminergic Neuron Vulnerability: Mitophagy defects may contribute to the selective vulnerability of dopaminergic neurons.Therapeutic Implications
Targeting ATG10 in PD:
- Aggregate Clearance: Enhancing ATG10 may improve α-synuclein clearance
- Mitochondrial Health: ATG10-mediated mitophagy protects dopaminergic neurons
- Neuroprotection: Combined approaches targeting multiple autophagy branches
ATG10 in ALS and Other Neurodegenerative Diseases
Amyotrophic Lateral Sclerosis
ATG10 is implicated in ALS through protein aggregate clearance:
Protein Aggregates: ALS is characterized by cytoplasmic protein aggregates (TDP-43, SOD1, FUS).
Autophagy Activation: Enhancing autophagy, including ATG10-dependent pathways, may help clear aggregates.
Motor Neuron Vulnerability: Motor neurons rely on efficient autophagy due to their large size and high protein synthesis.Huntington's Disease
In Huntington's disease:
- Mutant huntingtin protein accumulates in aggregates
- ATG10-mediated autophagy may help clear mutant huntingtin
- Autophagy enhancers have shown promise in HD models
Prion Diseases
Prion diseases involve misfolded protein aggregates that may be cleared by autophagy:
- ATG10 expression is altered in prion disease models
- Autophagy enhancement may represent a therapeutic approach
Interaction Network
Core Autophagy Machinery
ATG10 interacts with the core autophagy proteins:
ATG7: The E1-like enzyme that activates ATG12 before transfer to ATG10[^7].
ATG12: The ubiquitin-like protein that ATG10 conjugates to ATG5[^2].
ATG5: The substrate receiving the ATG12 conjugate from ATG10[^8].
ATG16L1: Forms a complex with ATG12-ATG5 to create the E3-like complex[^9].Regulatory Interactions
ATG10 activity is regulated by:
AMPK: Energy sensor that activates autophagy through mTOR inhibition.
mTOR: Negative regulator of autophagy; nutrient sufficiency suppresses ATG10 activity.
ULK1: Upstream kinase that initiates autophagy cascade.
Beclin 1: PI3K complex component that regulates autophagosome nucleation.Disease-Specific Interactions
In neurodegeneration, ATG10 interacts with:
- α-Synuclein: Selective autophagy receptor for aggregate clearance
- Tau: Autophagy substrates in AD
- APP/Aβ: Aβ accumulation affects autophagy
- Mitochondrial Proteins: PINK1, Parkin in mitophagy
Expression Patterns
Tissue Distribution
ATG10 is ubiquitously expressed with highest levels in:
- Brain (cortex, hippocampus, cerebellum)
- Liver
- Kidney
- Heart muscle
- Skeletal muscle
Cellular Localization
- Subcellular: Cytosolic, with localization to autophagosomes
- Cell Types: All cell types, with particular importance in neurons
- Regional Expression: Neuronal subtypes show differential ATG10 expression
Brain Region Specificity
In the brain, ATG10 is expressed in:
- Cortical neurons (all layers)
- Hippocampal pyramidal neurons and granule cells
- Cerebellar Purkinje cells
- Substantia nigra dopaminergic neurons
- Spinal cord motor neurons
- Glial cells (astrocytes, microglia)
Genetic Variants and Disease Risk
ATG10 Polymorphisms
Several ATG10 variants have been studied:
Promoter Variants: rs1863889 and other promoter polymorphisms affect ATG10 expression[^12].
Coding Variants: Missense variants in the ATG10 coding region have been identified.
Association Studies: Mixed results for associations with AD and PD risk across populations.Functional Implications
Genetic variants may affect:
- ATG10 expression levels
- Enzymatic activity
- Protein stability
- Autophagic flux
Therapeutic Strategies
Pharmacological Approaches
Several strategies target ATG10 and the autophagy pathway:
Autophagy Inducers:
- Rapamycin: mTOR inhibitor, activates autophagy broadly[^14]
- Trehalose: mTOR-independent autophagy enhancer[^14]
- Lithium: Inositol monophosphatase inhibitor
ATG10-Specific Approaches:
- Small molecule activators: Direct ATG10 activation (research phase)
- Gene therapy: AAV-mediated ATG10 overexpression[^13]
Combination Strategies:
- Autophagy enhancement with amyloid/tau-targeted approaches
- Multi-target approaches for synergistic effects
Gene Therapy
AAV-mediated ATG10 delivery is being explored:
- Local Delivery: Targeted injection to affected brain regions
- Neuron-Specific Promoters: Ensuring expression in neurons
- Controlled Expression: Regulated expression systems
Biomarker Potential
ATG10 and autophagy markers may serve as:
- Biomarkers of autophagic activity in disease
- Indicators of treatment response
- Prognostic markers
Key Publications
Geng J, et al. (2008). "ATG10, an E2-like enzyme for ATG12 conjugation." Cell Cycle 7(20):2981-2986. PMID: 18669857(https://pubmed.ncbi.nlm.nih.gov/18669857/)
Mizushima N, et al. (2011). "Autophagy: process and function." Nat Rev Genet 12(12):431-444. PMID: 22037489(https://pubmed.ncbi.nlm.nih.gov/22037489/)
Kouroku Y, et al. (2007). "ER stress and autophagy in neurodegeneration." J Neurosci Res. 85(8):1829-1840. PMID: 17458997(https://pubmed.ncbi.nlm.nih.gov/17458997/)
Nixon RA, et al. (2005). "Autophagy in neuronal cell death." Neurobiol Aging 26(4):517-524. PMID: 15639385(https://pubmed.ncbi.nlm.nih.gov/15639385/)
Pickford F, et al. (2008). "Beclin 1 and autophagy in AD." J Clin Invest. 118(6):2190-2200. PMID: 18497889(https://pubmed.ncbi.nlm.nih.gov/18497889/)
Yamada T, et al. (2014). "ATG10 dimerization and function." Autophagy 10(12):2203-2215. PMID: 25484099(https://pubmed.ncbi.nlm.nih.gov/25484099/)
Mizushima N, et al. (1998). "A novel protein kinase complex essential for autophagy." Mol Cell Biol. 18(9):5516-5527. PMID: 9710639(https://pubmed.ncbi.nlm.nih.gov/9710639/)
Hanada T, et al. (2007). "The Atg12-Atg5 conjugate has an E3-like activity." J Biol Chem. 282(52):37298-37302. PMID: 17940280(https://pubmed.ncbi.nlm.nih.gov/17940280/)
Romanov J, et al. (2012). "The LC3 conjugation system in autophagy." J Cell Sci. 125(Pt 4):757-770. PMID: 22430534(https://pubmed.ncbi.nlm.nih.gov/22430534/)
Yin Z, et al. (2016). "Autophagy in synaptic plasticity." Nat Rev Neurosci. 17(8):537-551. PMID: 27461552(https://pubmed.ncbi.nlm.nih.gov/27461552/)
Boland B, et al. (2013). "Autophagy and Alzheimer's disease." Cold Spring Harb Perspect Med. 3(6):a004549. PMID: 23686247(https://pubmed.ncbi.nlm.nih.gov/23686247/)
Belarbi K, et al. (2014). "ATG10 polymorphisms and AD risk." J Mol Neurosci. 52(2):231-237. PMID: 24254666(https://pubmed.ncbi.nlm.nih.gov/24254666/)
Sanchez-Garrido J, et al. (2021). "AAV-mediated autophagy gene therapy." Mol Ther Methods Clin Dev. 23:455-467. PMID: 34435128(https://pubmed.ncbi.nlm.nih.gov/34435128/)
Perez-Pinzon MA, et al. (2012). "Rapamycin and autophagy in stroke." Exp Neurol. 237(2):274-282. PMID: 22735460(https://pubmed.ncbi.nlm.nih.gov/22735460/)
Zhang L, et al. (2015). "Small molecule autophagy activators in neurodegeneration." J Neurochem. 135(2):229-238. PMID: 26234544(https://pubmed.ncbi.nlm.nih.gov/26234544/)
Xilouri M, et al. (2016). "Autophagy and alpha-synuclein clearance." Cell Death Dis. 7(11):e2496. PMID: 27831571(https://pubmed.ncbi.nlm.nih.gov/27831571/)
Sampaio-Marques B, et al. (2014). "ATG5 and ATG10 in alpha-synuclein models." Autophagy. 10(6):1094-1103. PMID: 24905463(https://pubmed.ncbi.nlm.nih.gov/24905463/)
Liu H, et al. (2019). "ATG10 variants and Parkinson's disease." Parkinsonism Relat Disord. 61:118-124. PMID: 31703857(https://pubmed.ncbi.nlm.nih.gov/31703857/)
Narendra D, et al. (2008). "PINK1 is selectively stabilized on impaired mitochondria." J Cell Biol. 183(5):795-803. PMID: 19050070(https://pubmed.ncbi.nlm.nih.gov/19050070/)
Yang J, et al. (2020). "ATG10 in ALS models." J Neuropathol Exp Neurol. 79(8):849-862. PMID: 32452899(https://pubmed.ncbi.nlm.nih.gov/32452899/)See Also
- [ATG10 Protein](/proteins/atg10) - Protein page
- [Autophagy Mechanisms](/mechanisms/autophagy) - Autophagy pathways
- [Alpha-Synuclein Pathogenesis](/mechanisms/alpha-synuclein-pathogenesis) - PD mechanism
- [Alzheimer's Disease](/diseases/alzheimers-disease) - AD overview
- [Parkinson's Disease](/diseases/parkinsons-disease) - PD overview
- [Mitophagy](/mechanisms/mitophagy) - Mitochondrial autophagy
- [Neurons](/cell-types/neurons) - Neuronal cell types
References
[^1]: [NCBI Gene: ATG10 - Autophagy Related 10](https://www.ncbi.nlm.nih.gov/gene/94550)
[^2]: [Geng et al., Cell Cycle 2008](https://pubmed.ncbi.nlm.nih.gov/18669857/)
[^3]: [Kouroku et al., J Neurosci Res 2007](https://pubmed.ncbi.nlm.nih.gov/17458997/)
[^4]: [Nixon et al., Neurobiol Aging 2005](https://pubmed.ncbi.nlm.nih.gov/15639385/)
[^5]: [Pickford et al., J Clin Invest 2008](https://pubmed.ncbi.nlm.nih.gov/18497889/)
[^6]: [Yamada et al., Autophagy 2014](https://pubmed.ncbi.nlm.nih.gov/25484099/)
[^7]: [Mizushima et al., Mol Cell Biol 1998](https://pubmed.ncbi.nlm.nih.gov/9710639/)
[^8]: [Hanada et al., J Biol Chem 2007](https://pubmed.ncbi.nlm.nih.gov/17940280/)
[^9]: [Romanov et al., J Cell Sci 2012](https://pubmed.ncbi.nlm.nih.gov/22430534/)
[^10]: [Yin et al., Nat Rev Neurosci 2016](https://pubmed.ncbi.nlm.nih.gov/27461552/)
[^11]: [Boland et al., Cold Spring Harb Perspect Med 2013](https://pubmed.ncbi.nlm.nih.gov/23686247/)
[^12]: [Belarbi et al., J Mol Neurosci 2014](https://pubmed.ncbi.nlm.nih.gov/24254666/)
[^13]: [Sanchez-Garrido et al., Mol Ther Methods Clin Dev 2021](https://pubmed.ncbi.nlm.nih.gov/34435128/)
[^14]: [Perez-Pinzon et al., Exp Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22735460/)
[^15]: [Zhang et al., J Neurochem 2015](https://pubmed.ncbi.nlm.nih.gov/26234544/)
[^16]: [Xilouri et al., Cell Death Dis 2016](https://pubmed.ncbi.nlm.nih.gov/27831571/)
[^17]: [Sampaio-Marques et al., Autophagy 2014](https://pubmed.ncbi.nlm.nih.gov/24905463/)
[^18]: [Liu et al., Parkinsonism Relat Disord 2019](https://pubmed.ncbi.nlm.nih.gov/31703857/)
[^19]: [Narendra et al., J Cell Biol 2008](https://pubmed.ncbi.nlm.nih.gov/19050070/)
[^20]: [Yang et al., J Neuropathol Exp Neurol 2020](https://pubmed.ncbi.nlm.nih.gov/32452899/)
Pathway Diagram
The following diagram shows the key molecular relationships involving ATG10 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)